Current and future hepatitis C virus diagnostic testing: problems and advancements.
Serological antibody assays used in hepatitis C virus diagnosis have improved in sensitivity and specificity. However, detection of active viremia or monitoring levels of virus during or after patient treatment is most commonly undertaken using nucleic acid-based technologies. Advancements in diagnostic technologies and implications for managing patients with hepatitis C in various clinical settings are discussed.
Majid
Ayaz M
AM
Department of Laboratory Medicine, University of Washington Medical Center, Seattle, WA 98104-2499, USA.
Gretch
David R
DR
D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D011933:Reagent Kits, Diagnostic / Q000639:trends; D012698:Serologic Tests / Q000379:methods / Q000639:trends*; D014766:Viremia / Q000175:diagnosis / Q000821:virology
D018937:Hepatitis C Antibodies; D011933:Reagent Kits, Diagnostic